Biotechnology
| Symbol | Name | Price (Intraday) |
|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 489.23 |
| BNTX | BioNTech SE | 176.17 |
| ALXN | Alexion Pharmaceuticals, Inc. | 166.66 |
| BGNE | BeiGene, Ltd. | 350.75 |
With this context and industry outlook in mind, let's start our list of 10 best biotech stocks to buy for 2021.
XBIT, BDSI, and ACRS are top for value, growth, and momentum, respectively. The biotechnology industry includes companies that develop drugs and diagnostic technologies for the treatment of diseases and medical conditions.
Biocon Limited is the Largest Biotechnology Companies in India which has turnover of Rs 6315 Cr.
The best stocks to buy for 2021:
Jeff Bezos-backed startup Nautilus Biotechnology set to go public via SPAC at $900M valuation. Nautilus Biotechnology, a Seattle-based biotech startup led by Isilon co-founder Sujal Patel, is the latest company to go public using a special purpose acquisition company, or SPAC.
Rankings
| Rank | Company | Market Cap in 2019 (USD billions) |
|---|---|---|
| 1 | Johnson & Johnson NYSE: JNJ | 385.0 |
| 2 1 | Roche SIX: ROG | 281.1 |
| 3 2 | Pfizer NYSE: PFE | 216.7 |
| 4 1 | Novartis NYSE: NVS | 240.0 |
That said, looking at the key qualitative drivers of biotech value—namely, a promising product pipeline, patents, talented management, durable partnerships and access to funds—offers a good first step in sizing up a company's potential.
Johnson & Johnson was honored as one of Fast Company's top ten most innovative biotech companies.
The year 2020-21 has not been short of a whirlwind but the stock markets soared over 80% from the lows of March 2020 to the end of FY21.
...
Warren Buffett's Berkshire Hathaway has bought 648,447 shares of Biogen at a combined worth of $192.4 million ahead of the FDA filing of a controversial Alzheimer's drug.
Gainers
| Company | Price | % Change |
|---|---|---|
| DVN Devon Energy Corp | 24.03 | +8.54% |
| HES Hess Corp | 75.94 | +7.79% |
| MRO Marathon Oil Corp | 11.75 | +6.43% |
| SYF Synchrony Financial | 43.03 | +5.65% |
Yet No Comments